CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Warts and verrucae - Management
Treatment options in secondary care
- Treatment options available in secondary care include:
- Physical ablation, such as surgery, laser treatment, and photodynamic treatment.
- Antimitotic treatments, such as topical podophyllotoxin, topical or oral retinoids, or intralesional bleomycin.
- Immunomodulatory treatments, such as topical sensitizers (dinitrochlorobenzene, diphencyprone, or squaric acid dibutylester), topical imiquimod 5%, or intralesional interferon.
- Virucidal treatments, such as formaldehyde and glutaraldehyde.
- Cantharadin (a potent blistering agent extracted from blister beetles) may be available in some secondary-care departments.
© NHS Institute for Innovation and Improvement